Research map: Classifications of rheumatological extraintestinal manifestations in inflammatory bowel disease: Unmet needs in clinical practice and trials Back to the article
Papers in this map Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial · Stephen B. Hanauer · 2002 · 4183 citations · Cited by this paperPractical Tips for Diagnosis and Management of Concomitant Inflammatory Spondyloarthritis and Inflammatory Bowel Disease · Katherine Falloon · 2025 · 5 citations · RelatedInfliximab for Induction and Maintenance Therapy for Ulcerative Colitis · Paul J. Rutgeerts · 2005 · 3926 citations · Cited by this paperInterpreting oral dysbiosis during nutritional therapy in pediatric Crohn disease · Huan Xu · 2026 · RelatedVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis · Brian G. Feagan · 2013 · 2918 citations · Cited by this paperUpadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study · 2026 · RelatedVedolizumab as Induction and Maintenance Therapy for Crohn's Disease · William J. Sandborn · 2013 · 2734 citations · Cited by this paperMast cell–derived IL-13 as a driver of Crohn disease–associated intestinal fibrosis · 2026 · RelatedAdalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial · Jean–Frédéric Colombel · 2006 · 2260 citations · Cited by this paperRisk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments · 2026 · RelatedUstekinumab as Induction and Maintenance Therapy for Crohn’s Disease · Brian G. Feagan · 2016 · 1860 citations · Cited by this paperTransmural healing is significantly associated with prevention of clinical relapse in Crohn’s disease · 2026 · RelatedThe Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general · Martín Rudwaleit · 2010 · 1776 citations · Cited by this paperColonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial · 2026 · RelatedTofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis · William J. Sandborn · 2017 · 1774 citations · Cited by this paperCancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD · 2026 · RelatedUstekinumab as Induction and Maintenance Therapy for Ulcerative Colitis · Bruce E. Sands · 2019 · 1226 citations · Cited by this paperInflammatory bowel disease in the aging population · 2026 · RelatedCertolizumab Pegol for the Treatment of Crohn's Disease · William J. Sandborn · 2007 · 1145 citations · Cited by this paperInflammatory bowel disease and risk of perineal injury in primiparous vaginal births: a retrospective cohort study · 2026 · RelatedAdalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial · William J. Sandborn · 2007 · 1041 citations · Cited by this paperAdalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab · William J. Sandborn · 2007 · 976 citations · Cited by this paperNatalizumab Induction and Maintenance Therapy for Crohn's Disease · William J. Sandborn · 2005 · 924 citations · Cited by this paperAdalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial · Walter Reinisch · 2011 · 894 citations · Cited by this paperExtraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management · Gerhard Rogler · 2021 · 882 citations · Cited by this paperSubcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis · William J. Sandborn · 2013 · 728 citations · Cited by this paperEffects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed · Bruce E. Sands · 2014 · 717 citations · Cited by this paperUpadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials · Silvio Danese · 2022 · 641 citations · Cited by this paperOzanimod as Induction and Maintenance Therapy for Ulcerative Colitis · William J. Sandborn · 2021 · 566 citations · Cited by this paperPeripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history · Timothy R. Orchard · 1998 · 553 citations · Cited by this paperUpadacitinib Induction and Maintenance Therapy for Crohn’s Disease · Edward V. Loftus · 2023 · 476 citations · Cited by this paperFilgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial · Brian G. Feagan · 2021 · 458 citations · Cited by this paperEtrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies · William J. Sandborn · 2023 · 366 citations · Cited by this paperMirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis · Geert D’Haens · 2023 · 356 citations · Cited by this paperRisankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial · Marc Ferrante · 2022 · 342 citations · Cited by this paperECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease · Hannah B. Gordon · 2023 · 314 citations · Cited by this paperThe Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis · Maren C. Karreman · 2016 · 249 citations · Cited by this paperThe pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis · Yu‐Tsan Lin · 2011 · 210 citations · Cited by this paperSelecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD · Catherine Le Berre · 2021 · 173 citations · Cited by this paperSource: OpenAlex (CC0)